Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II

Eun Jeong Yoon, Dokyun Kim, Hyukmin Lee, Hye Sun Lee, Jong Hee Shin, Young Uh, Kyeong Seob Shin, Young Ah Kim, Yoon Soo Park, Jeong Hwan Shin, Seok Hoon Jeong

Research output: Contribution to journalArticle

Abstract

This study was conducted to evaluate the possible clinical and bacteriologic features associated with 30-day mortality from Acinetobacter baumannii (A. baumannii) bloodstream infections (BSIs). We conducted a prospective, multicenter, observational study of 181 entire episodes of A. baumannii BSI from six general hospitals between May 2016 and April 2017 in South Korea. Cox proportional-hazards regression model was used to estimate risks of the primary endpoint, i.e., all-cause mortality within 30 days from the initial blood culture. Most (84.5%) of the A. baumannii blood isolates belonged to the international clonal lineage II (ICLII) and 89.5% of the isolates were either multidrug- or extensively-drug resistant. We identified three risk factors including the old age of patient {hazard ratio, 1.033; [95% Confidential Interval (CI), 1.010–1.056]}, the sequential organ failure assessment score [1.133 (1.041–1.233)], and causative A. baumannii sequence type (ST) 191 belonging to ICLII [1.918 (1.073–3.430)], and three protective factors including causative A. baumannii ST451 belonging to ICLII [0.228 (0.078–0.672)], platelet count [0.996 (0.993–0.999)], and definitive therapy within 72 h [0.255 (0.125–0.519)]. Differing 30-day mortality rate in the dominant ICLII was observed by ST, which was much high in ST191 and low in ST451 and it was likely associated with the molecular traits, rather than the drug resistance.

Original languageEnglish
Article number233
JournalFrontiers in Public Health
Volume7
DOIs
Publication statusPublished - 2019 Aug 16

Fingerprint

Acinetobacter baumannii
Clone Cells
Infection
Mortality
Organ Dysfunction Scores
Republic of Korea
Platelet Count
Proportional Hazards Models
Drug Resistance
General Hospitals
Multicenter Studies
Observational Studies
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Yoon, Eun Jeong ; Kim, Dokyun ; Lee, Hyukmin ; Lee, Hye Sun ; Shin, Jong Hee ; Uh, Young ; Shin, Kyeong Seob ; Kim, Young Ah ; Park, Yoon Soo ; Shin, Jeong Hwan ; Jeong, Seok Hoon. / Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II. In: Frontiers in Public Health. 2019 ; Vol. 7.
@article{b43a81d0b27142599096a98d57803632,
title = "Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II",
abstract = "This study was conducted to evaluate the possible clinical and bacteriologic features associated with 30-day mortality from Acinetobacter baumannii (A. baumannii) bloodstream infections (BSIs). We conducted a prospective, multicenter, observational study of 181 entire episodes of A. baumannii BSI from six general hospitals between May 2016 and April 2017 in South Korea. Cox proportional-hazards regression model was used to estimate risks of the primary endpoint, i.e., all-cause mortality within 30 days from the initial blood culture. Most (84.5{\%}) of the A. baumannii blood isolates belonged to the international clonal lineage II (ICLII) and 89.5{\%} of the isolates were either multidrug- or extensively-drug resistant. We identified three risk factors including the old age of patient {hazard ratio, 1.033; [95{\%} Confidential Interval (CI), 1.010–1.056]}, the sequential organ failure assessment score [1.133 (1.041–1.233)], and causative A. baumannii sequence type (ST) 191 belonging to ICLII [1.918 (1.073–3.430)], and three protective factors including causative A. baumannii ST451 belonging to ICLII [0.228 (0.078–0.672)], platelet count [0.996 (0.993–0.999)], and definitive therapy within 72 h [0.255 (0.125–0.519)]. Differing 30-day mortality rate in the dominant ICLII was observed by ST, which was much high in ST191 and low in ST451 and it was likely associated with the molecular traits, rather than the drug resistance.",
author = "Yoon, {Eun Jeong} and Dokyun Kim and Hyukmin Lee and Lee, {Hye Sun} and Shin, {Jong Hee} and Young Uh and Shin, {Kyeong Seob} and Kim, {Young Ah} and Park, {Yoon Soo} and Shin, {Jeong Hwan} and Jeong, {Seok Hoon}",
year = "2019",
month = "8",
day = "16",
doi = "10.3389/fpubh.2019.00233",
language = "English",
volume = "7",
journal = "Frontiers in Public Health",
issn = "2296-2565",
publisher = "Frontiers Media S. A.",

}

Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II. / Yoon, Eun Jeong; Kim, Dokyun; Lee, Hyukmin; Lee, Hye Sun; Shin, Jong Hee; Uh, Young; Shin, Kyeong Seob; Kim, Young Ah; Park, Yoon Soo; Shin, Jeong Hwan; Jeong, Seok Hoon.

In: Frontiers in Public Health, Vol. 7, 233, 16.08.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II

AU - Yoon, Eun Jeong

AU - Kim, Dokyun

AU - Lee, Hyukmin

AU - Lee, Hye Sun

AU - Shin, Jong Hee

AU - Uh, Young

AU - Shin, Kyeong Seob

AU - Kim, Young Ah

AU - Park, Yoon Soo

AU - Shin, Jeong Hwan

AU - Jeong, Seok Hoon

PY - 2019/8/16

Y1 - 2019/8/16

N2 - This study was conducted to evaluate the possible clinical and bacteriologic features associated with 30-day mortality from Acinetobacter baumannii (A. baumannii) bloodstream infections (BSIs). We conducted a prospective, multicenter, observational study of 181 entire episodes of A. baumannii BSI from six general hospitals between May 2016 and April 2017 in South Korea. Cox proportional-hazards regression model was used to estimate risks of the primary endpoint, i.e., all-cause mortality within 30 days from the initial blood culture. Most (84.5%) of the A. baumannii blood isolates belonged to the international clonal lineage II (ICLII) and 89.5% of the isolates were either multidrug- or extensively-drug resistant. We identified three risk factors including the old age of patient {hazard ratio, 1.033; [95% Confidential Interval (CI), 1.010–1.056]}, the sequential organ failure assessment score [1.133 (1.041–1.233)], and causative A. baumannii sequence type (ST) 191 belonging to ICLII [1.918 (1.073–3.430)], and three protective factors including causative A. baumannii ST451 belonging to ICLII [0.228 (0.078–0.672)], platelet count [0.996 (0.993–0.999)], and definitive therapy within 72 h [0.255 (0.125–0.519)]. Differing 30-day mortality rate in the dominant ICLII was observed by ST, which was much high in ST191 and low in ST451 and it was likely associated with the molecular traits, rather than the drug resistance.

AB - This study was conducted to evaluate the possible clinical and bacteriologic features associated with 30-day mortality from Acinetobacter baumannii (A. baumannii) bloodstream infections (BSIs). We conducted a prospective, multicenter, observational study of 181 entire episodes of A. baumannii BSI from six general hospitals between May 2016 and April 2017 in South Korea. Cox proportional-hazards regression model was used to estimate risks of the primary endpoint, i.e., all-cause mortality within 30 days from the initial blood culture. Most (84.5%) of the A. baumannii blood isolates belonged to the international clonal lineage II (ICLII) and 89.5% of the isolates were either multidrug- or extensively-drug resistant. We identified three risk factors including the old age of patient {hazard ratio, 1.033; [95% Confidential Interval (CI), 1.010–1.056]}, the sequential organ failure assessment score [1.133 (1.041–1.233)], and causative A. baumannii sequence type (ST) 191 belonging to ICLII [1.918 (1.073–3.430)], and three protective factors including causative A. baumannii ST451 belonging to ICLII [0.228 (0.078–0.672)], platelet count [0.996 (0.993–0.999)], and definitive therapy within 72 h [0.255 (0.125–0.519)]. Differing 30-day mortality rate in the dominant ICLII was observed by ST, which was much high in ST191 and low in ST451 and it was likely associated with the molecular traits, rather than the drug resistance.

UR - http://www.scopus.com/inward/record.url?scp=85072729526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072729526&partnerID=8YFLogxK

U2 - 10.3389/fpubh.2019.00233

DO - 10.3389/fpubh.2019.00233

M3 - Article

AN - SCOPUS:85072729526

VL - 7

JO - Frontiers in Public Health

JF - Frontiers in Public Health

SN - 2296-2565

M1 - 233

ER -